- Patient/Guest
- Phlebotomist
- Updates
| NBS 7 | - |
|---|
|
Screen newborns for 7 disorders |
||
 |
Synonym | See updates |
 |
Test Code | CDBIOPR0045 |
 |
Test Type | Biochemistry |
 |
Pre-Test Condition | See updates |
 |
Report Availability | 5 D(s) |
 |
# Test(s) | Multiple |
| Test details | Sample Report |
|---|---|
| NBS 7 |
|
|
Synonym | See updates | |
|
Test Code | CDBIOPR0045 | |
 |
Test Category | Metabolic disorders | |
|
Pre-Test Condition | See updates | |
 |
Medical History | See updates | |
|
Report Availability | 5 D(s) | |
 |
Specimen/Sample | Dried blood spot; 1; Filter paper | |
 |
Stability @21-26 deg. C | NA | |
 |
Stability @ 2-8 deg. C | NA | |
 |
Stability @ Frozen | NA | |
|
# Test(s) | Multiple | |
 |
Processing Method | Mass Spectrometry | |
| **NBS 7 Parameters****FDA Status**: FDA-approved for newborn screening.**Other Names**: Newborn Screening Core Panel, NBS 7 Test.**Historical Breakthrough**: Developed in the 1960s for early metabolic screening, advancing pediatrics.**Key Purpose and Impact**: Screens for 7 core metabolic disorders (e.g., PKU, congenital hypothyroidism) in newborns.**Preparation and Patient History**: Heel prick blood; report newborn health or family history.**Consent Requirement**: Standard consent with parental consent.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects disorders in ~90% of cases; guides early intervention.**References Cited**: Testing.com Newborn Screening Tests 2023; Labcorp NBS Panel 2025; UpToDate Newborn Screening 2025 |